Literature DB >> 13129590

Glucose transporter type1 (GLUT-1) deficiency.

Neil Gordon1, Richard W Newton.   

Abstract

Glucose transporter type1 (GLUT-1) deficiency may be rare, but it is a preventable cause of severe learning difficulties; and therefore there is an urgency in making an early diagnosis. Suspicions must be roused when intractable seizures occur in infancy. These may be associated with acquired microcephaly and developmental delay. The finding of low glucose sugar levels in the cerebrospinal fluid, but not in the blood will identify the condition. The gene encoding the GLUT-1 protein is located on the short arm of chromosome 1, and inheritance is by a dominant trait. Patients with this syndrome can have heterozygous mutations, with one allele being a normal wild type and one being mutant. An efficient transport of glucose across the blood-brain barrier is essential as it is such an important fuel for the brain, and this is provided by glucose transporter type1 in the endothelial cells of the brain capillaries. Another minor contribution to the symptomatology of GLUT-1 may be impaired transport of an oxidised form of vitamin C. Treatment with anti-epileptic drugs may be needed, and the ketogenic diet may reduce symptoms, as ketosis can provide an alternative source of fuel for the brain. It has also been suggested that antioxidant thioctic acid may be of benefit. Substances such as caffeine and phenobarbitone should be avoided as they inhibit glucose transport.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13129590     DOI: 10.1016/s0387-7604(03)00058-5

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  8 in total

Review 1.  Solute Carriers in the Blood-Brain Barier: Safety in Abundance.

Authors:  Katarzyna A Nałęcz
Journal:  Neurochem Res       Date:  2016-08-09       Impact factor: 3.996

Review 2.  Alternative approaches to conventional antiepileptic drugs in the management of paediatric epilepsy.

Authors:  R Kneen; R E Appleton
Journal:  Arch Dis Child       Date:  2006-11       Impact factor: 3.791

3.  Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion.

Authors:  Ayse Kubra Coskun; Richard E Sutton
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 4.  Vitamin C transporters.

Authors:  C I Rivas; F A Zúñiga; A Salas-Burgos; L Mardones; V Ormazabal; J C Vera
Journal:  J Physiol Biochem       Date:  2008-12       Impact factor: 4.158

5.  The neuroprotective effect of cornus MAS on brain tissue of Wistar rats.

Authors:  Renata Francik; Jadwiga Kryczyk; Mirosław Krośniak; Mehmet Berköz; Ilona Sanocka; Sławomir Francik
Journal:  ScientificWorldJournal       Date:  2014-10-16

6.  Primordial odontogenic tumor: An immunohistochemical profile.

Authors:  R Bologna-Molina; T Mikami; V Pereira-Prado; F-R Pires; R Carlos-Bregni; A Mosqueda-Taylor
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-05-01

Review 7.  Paroxysmal Movement Disorders.

Authors:  Susan Harvey; Mary D King; Kathleen M Gorman
Journal:  Front Neurol       Date:  2021-06-11       Impact factor: 4.003

Review 8.  Can psychiatric childhood disorders be due to inborn errors of metabolism?

Authors:  A Simons; F Eyskens; I Glazemakers; D van West
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-09-30       Impact factor: 4.785

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.